Processing of cholecystokinin by isolated liver cells

The role of the liver in processing cholecystokinin (CCK) remains partially understood. While it is known that the liver removes CCK from circulation, the specific cell type and mechanism responsible for this process have not been fully characterized. Earlier studies have shown that the liver can extract CCK, but the details of how this occurs are unclear. The involvement of hepatocytes, Kupffer cells, or hepatic endothelial cells in CCK uptake is uncertain. The specificity of CCK extraction by the liver has been noted, but the molecular mechanisms are not well defined. The influence of anions and other transport inhibitors on CCK uptake is an area requiring further investigation. The metabolic fate of CCK after uptake is also not fully understood. This uncertainty has driven the need for a more detailed analysis of CCK processing by isolated liver cells. Understanding these mechanisms may help clarify the liver's role in regulating CCK levels in the body.

This study aimed to identify the liver cell type responsible for cholecystokinin (CCK) uptake and to characterize the mechanism involved. The researchers focused on hepatocytes, Kupffer cells, and hepatic endothelial cells to determine which cell type is primarily involved in CCK processing. The study sought to evaluate the specificity of CCK uptake and compare it to findings from isolated perfused liver models. The goal was to assess whether the uptake process is saturable and influenced by various inhibitors. The researchers also aimed to determine the role of extracellular ions in CCK uptake. They wanted to investigate the temperature dependence of the process and whether it is active or passive. The study also examined the metabolic transformation of CCK after uptake. By addressing these questions, the researchers hoped to clarify the liver's role in CCK regulation.

The researchers used isolated rat liver cells, including hepatocytes, Kupffer cells, and hepatic endothelial cells, to study cholecystokinin (CCK) uptake. They labeled CCK peptides with iodine-125 to track their movement and metabolism. The cells were exposed to radiolabeled CCK-8 and CCK-33 to compare uptake rates. They tested the effect of various concentrations of unlabeled CCK-4 on the uptake of 125I-CCK-8. The study included metabolic inhibitors to assess the energy dependence of the process. Organic anions and a proteolytic enzyme were used to evaluate their impact on CCK uptake. The researchers also tested the influence of extracellular ions, such as sodium, calcium, and magnesium, on the process. They monitored the release of radiolabeled CCK over time to determine the metabolic fate of the peptides. These methods allowed the team to characterize the uptake and processing of CCK in different liver cell types.

Hepatocytes were the only liver cell type to show significant uptake of 125I-labeled cholecystokinin octapeptide (CCK-8). The uptake of CCK-8 by hepatocytes was sevenfold higher than that of CCK-33, similar to findings in the isolated perfused liver. The process was saturable, with 10(-4) M CCK-4 inhibiting uptake by 85%. Uptake was rapid, temperature-dependent, and reduced by metabolic inhibition. Trypsin, an enzyme that breaks down proteins, also decreased CCK-8 uptake. Organic anions like sulfobromophthalein and taurocholic acid reduced uptake, as did the anion transport inhibitor 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid. The process was dependent on extracellular anions but not on sodium, calcium, or magnesium. After uptake, hepatocytes released radiolabeled CCK in metabolized forms over time. These results suggest that the uptake mechanism resembles that of organic anions and small, cyclic peptides.

The study suggests that hepatocytes are the primary liver cells responsible for cholecystokinin (CCK) uptake. The process is active, anion-dependent, and resembles the uptake of organic anions and small, cyclic peptides. The findings indicate that small, linear peptides like CCK may be extracted by hepatocytes through a similar mechanism. The researchers propose that the uptake process is saturable and influenced by extracellular anions. The temperature dependence and sensitivity to metabolic inhibitors suggest an energy-requiring mechanism. The release of radiolabeled CCK in metabolized forms implies that the liver processes CCK after uptake. The study highlights the role of anion transport in CCK extraction. These conclusions align with the observed effects of anion transport inhibitors and organic anions on uptake rates.